Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital.

[1]  A. Gales,et al.  OXA-72-producing Acinetobacter baumannii in Brazil: a case report. , 2011, The Journal of antimicrobial chemotherapy.

[2]  G. Barnaud,et al.  Two sequential outbreaks caused by multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 or OXA-72 oxacillinase in an intensive care unit in France. , 2010, The Journal of hospital infection.

[3]  E. Culebras,et al.  A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. , 2010, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[4]  P. Higgins,et al.  Global spread of carbapenem-resistant Acinetobacter baumannii. , 2010, The Journal of antimicrobial chemotherapy.

[5]  P. Nordmann,et al.  Diversity, Epidemiology, and Genetics of Class D β-Lactamases , 2009, Antimicrobial Agents and Chemotherapy.

[6]  Occurrence of OXA-107 and ISAba1 in Carbapenem-Resistant Isolates of Acinetobacter baumannii from Croatia , 2009, Journal of Clinical Microbiology.

[7]  N. Woodford,et al.  Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. , 2009, International journal of antimicrobial agents.

[8]  N. Woodford,et al.  Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase. , 2009, The Journal of antimicrobial chemotherapy.

[9]  L. Dijkshoorn,et al.  Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. , 2008, The Journal of antimicrobial chemotherapy.

[10]  Harald Seifert,et al.  Acinetobacter baumannii: Emergence of a Successful Pathogen , 2008, Clinical Microbiology Reviews.

[11]  K. Towner,et al.  Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  Qiwen Yang,et al.  Molecular Epidemiology of Clinical Isolates of Carbapenem-Resistant Acinetobacter spp. from Chinese Hospitals , 2007, Antimicrobial Agents and Chemotherapy.

[13]  M. Kaufmann,et al.  Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  N. Woodford,et al.  Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. , 2006, The Journal of antimicrobial chemotherapy.

[15]  P. Nordmann,et al.  Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  M. Kaufmann,et al.  The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. , 2006, FEMS microbiology letters.

[17]  P. Nordmann,et al.  Genetic Structures at the Origin of Acquisition and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene blaOXA-58 in Acinetobacter baumannii , 2006, Antimicrobial Agents and Chemotherapy.

[18]  N. Woodford,et al.  Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. , 2006, International journal of antimicrobial agents.

[19]  A. Maniatis,et al.  Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit. , 2006, The Journal of antimicrobial chemotherapy.

[20]  L. Dijkshoorn,et al.  Standardization and Interlaboratory Reproducibility Assessment of Pulsed-Field Gel Electrophoresis-Generated Fingerprints of Acinetobacter baumannii , 2005, Journal of Clinical Microbiology.

[21]  J. Lupski,et al.  Microbial DNA Typing by Automated Repetitive-Sequence-Based PCR , 2005, Journal of Clinical Microbiology.

[22]  N. Woodford,et al.  Endemic Carbapenem Resistance Associated with OXA-40 Carbapenemase among Acinetobacter baumannii Isolates from a Hospital in Northern Spain , 2002, Journal of Clinical Microbiology.

[23]  Y. Arakawa,et al.  Convenient Test for Screening Metallo-β-Lactamase-Producing Gram-Negative Bacteria by Using Thiol Compounds , 2000, Journal of Clinical Microbiology.

[24]  G. Cornaglia,et al.  Appearance of IMP-1 metallo-β-lactamase in Europe , 1999, The Lancet.

[25]  P. Gerner-Smidt,et al.  Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp , 1997, Journal of clinical microbiology.

[26]  O. Gaillot,et al.  Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. , 1995, FEMS microbiology letters.

[27]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[28]  P. Visca,et al.  Annals of Clinical Microbiology and Antimicrobials Open Access in Vitro Activity of Tigecycline in Combination with Various Antimicrobials against Multidrug Resistant Acinetobacter Baumannii , 2022 .

[29]  N. Woodford,et al.  Molecular bacteriology: protocols and clinical applications , 1998 .

[30]  M. Kaufmann.  Pulsed-field gel electrophoresis. , 1998, Methods in molecular medicine.